mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.048 |
0.8 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |